FDA Ortho Panel Gives Advice On Spinal Device Trial Design

FDA should be flexible in its protocol guidelines for clinical trials of implanted devices for treating mild to moderate back pain, members of FDA's Orthopaedic & Rehabilitation Devices Panel agreed Sept. 9